Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Barclays Plc LSE:BARC London Ordinary Share GB0031348658 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.86 -2.57% 146.34 146.36 146.44 152.50 145.96 152.50 12,431,445 08:58:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Banks 21,632.0 4,357.0 14.3 10.2 25,391

BARCLAYS PLC: FORM 38.5(b)- Osmotica Pharmaceuticals plc

20/11/2020 12:48pm

UK Regulatory (RNS & others)


Barclays (LSE:BARC)
Historical Stock Chart


From Oct 2020 to Nov 2020

Click Here for more Barclays Charts.
TIDMBARC 
 
 

Ap27

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 
Name of exempt principal trader:         BARCLAYS CAPITAL INC 
Company dealt in                         OSMOTICA PHARMACEUTICALS PLC 
Class of relevant security to which the  US$0.01 ordinary shares 
dealings being disclosed relate 
Date of dealing                          19 November 2020 
 

2. INTERESTS AND SHORT POSITIONS

 

a.Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 
Class of relevant security:               ORD 
                                          Interests      Short Positions 
                                          Number  (%)    Number     (%) 
(1)   Relevant securities owned 
                                          320     0.00%  0          0.00% 
 
(2)   Derivatives (other than options): 
                                          0       0.00%  0          0.00% 
 
(3)   Options and agreements to 
 purchase/sell:                           0       0.00%  0          0.00% 
 
 
 TOTAL:                                   320     0.00%  0          0.00% 
 
 

b.Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 2)

 
Class of relevant security:                  Long           Short 
                                             Number    (%)  Number    (%) 
(1) Relevant securities 
(2) Derivatives (other than options) 
(3) Options and agreements to purchase/sell 
Total 
 
 

Ap28

 

3. DEALINGS (Note 3)

 

a. Purchases and sales

 
Purchase/sale  Number of   Price per unit 
               securities 
Purchase       1           6.0900   USD 
Purchase       100         6.0800   USD 
Purchase       100         6.0700   USD 
Purchase       200         6.0600   USD 
Purchase       300         6.1016   USD 
Purchase       400         6.0325   USD 
Purchase       713         6.0661   USD 
Sale           1           6.0900   USD 
Sale           1,813       6.0649   USD 
 

b. Derivatives transactions (other than options transactions)

 
Product name,  Nature of transaction  Number of relevant        Price per unit 
 e.g. CFD       (Note 5)              securities (Note 6)        (Note 4) 
 
 

c. Options transactions in respect of existing relevant securities

 

i. Writing, selling, purchasingor varying

 
Product  Writing,     Number of   Exercise  Type,      Expiry    Option money 
name,    selling,     securities  price     e.g.       date      paid/received 
e.g.     purchasing,  to which              American,            per unit 
call     varying      the option            European             (Note 4) 
option   etc.         relates               etc. 
                      (Note 7) 
 
 

ii. Exercising

 
Product name,      Number of securities  Exercise price per unit (Note 4) 
 e.g. call option 
 
 

d. Other dealings (including transactions in respect of new securities) (Note 3)

 
Nature of transaction  Details  Price per unit 
 (Note 7)                        (if applicable) (Note 4) 
 
 

Ap29

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

None

 
Is a Supplemental Form 38.5(b) attached?  NO 
Date of disclosure:                       20 Nov 2020 
Contact name:                             Large Holdings Regulatory Operations 
Telephone number:                         020 3134 7213 
Name of offeree/offeror with which 
 connected 
Nature of connection 
 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20201120005418/en/

 
    CONTACT: 

BARCLAYS PLC

 
    SOURCE: BARCLAYS PLC 
Copyright Business Wire 2020 
 

(END) Dow Jones Newswires

November 20, 2020 07:48 ET (12:48 GMT)

1 Year Barclays Chart

1 Year Barclays Chart

1 Month Barclays Chart

1 Month Barclays Chart
ADVFN Advertorial
Your Recent History
LSE
BARC
Barclays
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201125 09:13:21